Histone Demethylase Associated With Non-Small Cell Lung Cancer

by Bidita Debnath on  November 10, 2013 at 11:08 PM Research News
RSS Email Print This Page Comment
One of the leading causes of cancer deaths worldwide is Non-small cell lung cancer (NSCLC). Current therapies that target cellular kinases have been effective for some patients.
 Histone Demethylase Associated With Non-Small Cell Lung Cancer
Histone Demethylase Associated With Non-Small Cell Lung Cancer

However, many individuals with NSCLS do not respond. Recent studies of other cancers indicate that the global changes in DNA methylation patterns may drive tumor formation.

In this issue of the Journal of Clinical Investigation, MinGyu Lee and colleagues at MD Anderson Cancer Center evaluated histone methylation modifications in NSCLS cell lines and determined that the histone demethylase KDM2A was upregulated in NSCLC cell lines.

Furthermore, induced KDM2A expression increased cell proliferation and invasiveness through activation of the ERK1/2 signaling pathway. Evaluation of tumors from NSCLS patients uncovered a correlation between increased levels of KDM2A and poor prognosis.

This study suggests that therapies targeting KDM2A may benefit a subset of NSCLS patients.

Source: Eurekalert

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Lung Biopsy Lung Cancer Malignant Mesothelioma Cancer and Homeopathy Parkinsons Disease Surgical Treatment Cancer Facts Asbestosis Cancer Tattoos A Body Art Epigenetics 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive